Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Jason Aryeh Insider Profile

25 Followers

Jason Aryeh, Director at Orchestra BioMed Holdings, holds 118.12K shares in Orchestra BioMed Holdings (Ticker: OBIO), holds ― shares in Immunomedics (Ticker: IMMU), holds 115.58K shares in Ligand Pharma (Ticker: LGND). Most recently, Jason Aryeh Bought ― shares of Orchestra BioMed Holdings on May 20, 2026 for an estimated value of $2.49K.

Jason Aryeh's Trading History

LGNDLigand Pharma		Jun 12, 2026DirectorInformative Sell1.25M$37.30M
LFCRLifecore Biomedical		Jun 05, 2026DirectorUninformative Buy―$447.79K
OBIOOrchestra BioMed Holdings		May 20, 2026DirectorInformative Buy2.49K$698.08K
MACKMerrimack Pharmaceuticals		Jul 18, 2019―Informative Buy1.64K$57.52K
ARLZQAralez Pharmaceuticals		May 24, 2017―Informative Sell556.48K$109.57
NVLNFNovelion Therapeutics		May 17, 2017―Informative Buy3.23K$375.91K
VXRTVaxart		Mar 17, 2011DirectorInformative Sell28.76K$56.67K
ANEBAnebulo Pharmaceuticals		―Director――
IMMUImmunomedics		――――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jason Aryeh insider profile FAQ

What is the percentage of profitable transactions made by Jason Aryeh?
The percentage of profitable transactions made by Jason Aryeh is 40%.
What is the average return per transaction made by Jason Aryeh?
The average return per transaction made by Jason Aryeh is 2.40%.
What stocks does Jason Aryeh hold?
Jason Aryeh holds: OBIO, IMMU, LFCR, LGND, MACK, ARLZQ, ANEB, NVLNF, VXRT stocks.
What was Jason Aryeh’s latest transaction?
Jason Aryeh’s latest transaction was an Informative Buy of $2.49K.
What was Jason Aryeh's most profitable transaction?
Jason Aryeh’s most profitable transaction was an Informative Buy of OBIO stock on September 19, 2025. The return on the trade was 149.10%.
What is Jason Aryeh's role in Orchestra BioMed Holdings?
Jason Aryeh's role in Orchestra BioMed Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.